Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with …
…, H Nagasawa, H Ogawa, N Sekiguchi, H Takei… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: Acute/subacute interstitial pneumonia (A/SIP) in patients with polymyositis/dermatomyositis
(PM/DM) is frequently fatal within months despite high dose prednisolone (PSL) …
(PM/DM) is frequently fatal within months despite high dose prednisolone (PSL) …
Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study
…, R Sakai, T Kurasawa, T Kondo, H Takei… - …, 2020 - academic.oup.com
Objective To evaluate the efficacy and safety of tocilizumab (TCZ) monotherapy for large
vessel vasculitides (LVV), including Takayasu arteritis (TAK) and GCA. Methods Twelve …
vessel vasculitides (LVV), including Takayasu arteritis (TAK) and GCA. Methods Twelve …
Current clinical evidence of tocilizumab for the treatment of ANCA-associated vasculitis: a prospective case series for microscopic polyangiitis in a combination with …
…, K Chino, A Shibata, Y Okada, H Takei… - Clinical …, 2017 - Springer
The purpose of this study is to report the efficacy and safety of a combination of tocilizumab (TCZ)
and high-dose corticosteroid (CS) in two patients with microscopic polyangiitis (MPA) …
and high-dose corticosteroid (CS) in two patients with microscopic polyangiitis (MPA) …
Tocilizumab monotherapy for polymyalgia rheumatica: a prospective, single‐center, open‐label study
…, T Kurasawa, A Okuyama, H Takei… - International Journal …, 2019 - Wiley Online Library
Objectives Polymyalgia rheumatica (PMR) is a systemic inflammatory disease in the elderly
of unknown etiology. While glucocorticoids are the mainstay of treatment for PMR, various …
of unknown etiology. While glucocorticoids are the mainstay of treatment for PMR, various …
Incidence of cytomegalovirus reactivation in patients with inflammatory connective tissue diseases who are under immunosuppressive therapy.
…, H Ogawa, A Iizuka, N Sekiguchi, H Takei… - The Journal of …, 2004 - jrheum.org
Incidence of Cytomegalovirus Reactivation in Patients with Inflammatory Connective Tissue
Diseases Who Are Under Immunosuppressi Page 1 Personal non-commercial use only. The …
Diseases Who Are Under Immunosuppressi Page 1 Personal non-commercial use only. The …
A case of multiple giant coronary aneurysms and abdominal aortic aneurysm coexisting with IgG4-related disease
H Takei, H Nagasawa, R Sakai, K Nishimura… - Internal …, 2012 - jstage.jst.go.jp
IgG4-related disease (IgG4RD) is a unique systemic lymphoproliferative disorder characterized
by elevated serum IgG4 levels and IgG4-producing plasma cell expansion in the affected …
by elevated serum IgG4 levels and IgG4-producing plasma cell expansion in the affected …
Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review
…, H Nagasawa, E Nishi, A Okuyama, H Takei… - Clinical …, 2012 - Springer
Adult-onset Still’s disease (AOSD) is a systemic inflammatory disease of unknown etiology.
Recently, it has been reported that quite a few cases of refractory AOSD were successfully …
Recently, it has been reported that quite a few cases of refractory AOSD were successfully …
Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis
…, H Nagasawa, N Sekiguchi, H Takei… - Modern …, 2007 - academic.oup.com
We evaluated the efficacy and safety of low-dose cyclosporine A (CsA) in patients with
refractory lupus nephritis. Nine patients with systemic lupus erythematosus who had lupus …
refractory lupus nephritis. Nine patients with systemic lupus erythematosus who had lupus …
Single center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus
…, H Kameda, K Amano, H Nagasawa, H Takei… - Rheumatology …, 2011 - Springer
The aim of this study was to prospectively evaluate the efficacy and safety of tacrolimus (TAC)
in various manifestations of systemic lupus erythematosus (SLE) patients in daily clinical …
in various manifestations of systemic lupus erythematosus (SLE) patients in daily clinical …
Corticosteroid-free treatment of tocilizumab monotherapy for microscopic polyangiitis: a single-arm, single-center, clinical trial
…, A Shibata, K Chino, A Okuyama, H Takei… - Modern …, 2016 - academic.oup.com
Objectives: To assess the efficacy of tocilizumab (TCZ) monotherapy for the remission induction
of microscopic polyangiitis (MPA) in a prospective single-arm, single-center, cohort, pilot …
of microscopic polyangiitis (MPA) in a prospective single-arm, single-center, cohort, pilot …